Role of Rho-ROCK signaling in MOLT4 cells metastasis induced by CCL25

Leukemia Research

Volumn 35, Issue 1, 2011, Pages 103-109

  Zhang, Li ^a   Yu, Beibei ^a   Hu, Meng ^a   Wang, Zhan ^a   Liu, Dongying ^a   Tong, Xiaoling ^a   Leng, Jun ^a   Zhou, Beibei ^a   Hu, Yi ^a   Wu, Ranran ^a   Ding, Qianshan ^a   Zhang, Qiuping ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

CCL25; CCR9; Metastasis; MOLT4; Polarization; RhoA ROCK MLC

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CCL25 CHEMOKINE; CHEMOKINE; EXOENZYME C3; MYOSIN LIGHT CHAIN; PROTEIN KINASE; PROTEIN ROCK; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; LEUKEMIA; LEUKEMIA CELL LINE; LEUKEMOGENESIS; METASTASIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL LINE; CHEMOKINES, CC; HUMANS; NEOPLASM METASTASIS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN;

EID: 78650171303     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.07.039     Document Type: Article

References (35)

1. Liotta L.A., Rao C.N., Wewer U.M. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986, 55:1037-1057.
2. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242.
3. Kajiyama H., Shibata K., Terauchi M., Ino K., Nawa A., Kikkawa F. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 2008, 122:91-99.
4. Nieto M., Frade J.M., Sancho D., Mellado M., Martinez A.C., Sanchez-Madrid F. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis. J Exp Med 1997, 186(1):153-158.
5. Youn B.S., Kim C.H., Smith F.O., Broxmeyer H.E. TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor. Blood 1999, 94:2533-2536.
6. Letsch A., Keilholz U., Schadendorf D., Assfalg G., Asemissen A.M., Thiel E., et al. Functional CCR9 expression is associated with small intestinal metastasis. J Invest Dermatol 2004, 122:685-690.
7. Zhang Q.P., Li Q., Hu C.S., Zhang X.L., Huang B.J., Yang M.Z., et al. Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia. Cancer Res 2003, 63:6469-6477.
8. Bar-Sagi D., Hall A. Ras and Rho GTPases: a family reunion. Cell 2000, 103:227-238.
9. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635.
10. Leve F., de Souza W., Morgado-Díaz J.A. A cross-link between protein kinaseA and Rho-family GTPases signaling mediates cell-cell adhesion and actin cytoskeleton organization in epithelial cancer cells. J Pharmacol Exp Ther 2008, 327:777-788.
11. Ellenbroek S.I.J., Collard J.G. Rho GTPases: functions and association with cancer. Clin Exp Metastasis 2007, 24:657-672.
12. Nakamori S., Tamura S., Arai I., Kameyama M., Furukawa F., Ishikawa O., et al. Increased expression of RhoAp21 protein is involved in progression and metastasis of colorectal carcinoma. Recent advances in gastroenterological carcinogenesis I 1996, 901-904. Monduzzi Editore, Italy. E. Tahara, K. Sugimachi, T. Oohara (Eds.).
13. Yoshioka K., Nakamori S., Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999, 59(8):2004-2010.
14. Bartolomé R.A., Gálvez B.G., Longo N., Baleux F., van Muijen G.N.P., Sánchez-Mateos P., et al. Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. Cancer Res 2004, 64(7):2534-2543.
15. Li B., Zhao W.D., Tan Z.M., Fang W.G., Zhu L., Chen Y.H. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 2006, 580:4252-4260.
16. Poppe D., Tiede I., Fritz G., Becker C., Bartsch B., Wirtz S., et al. Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav Guanosine Exchange Activity on Rac proteins. J Immunol 2006, 176:640-651.
17. Itoh K., Yoshioka K., Akedo H., Uehata M., Ishizaki T., Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999, 5(2):221-225.
18. Fritz G., Just I., Kaina B. Rho GTPases are overexpressed in human tumors. Int J Cancer 1999, 81(5):682-687.
19. Faried A., Faried L.S., Usman N., Kato H., Kuwano H. Clinical and prognostic significance of rhoA and rhoC gene expression in esophageal squamous cell carcinoma. Ann Surg Oncol 2007, 14(12):3593-3601.
20. Wyckoff J.B., Pinner S.E., Gschmeissner S., Condeelis J.S., Sahai E. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 2006, 16:1515-1523.
21. Hakuma N., Kinoshita I., Shimizu Y., Yamazaki K., Yoshida K., Nishimura M., et al. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Cancer Res 2005, 65:10776-10782.
22. Barreiro O., de la Fuente H., Mittelbrunn M., Sánchez-Madrid F. Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions. Immunol Rev 2007, 218:147-164.
23. Matsukawa A., Hogaboam C.M., Lukacs N.W., Lincoln P.M., Evanoff H.L., Kunkel S.L. Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response. J Immunol 2000, 164:5362-5368.
24. Balkwill F. Chemokine biology in cancer. Semin Immunol 2003, 15:49-55.
25. Raman D., Baugher P.J., Thu Y.M., Richmond A. Role of chemokines in tumor growth. Cancer Lett 2007, 256:137-165.
26. Kunkel E.J., Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002, 16(1):1-4.
27. Nobes C.D., Hall A. Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 1995, 23:456-459.
28. Yoshioka K., Matsumura F., Akedo H., Itoh K. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J Biol Chem 1998, 273:5146-5154.
29. Itoh K., Yoshioka K., Akedo H., Uehata M., Ishizaki T., Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999, 5:221-225.
30. Sánchez-Madrid F., del Pozo M.A. Leukocyte polarization in cell migration and immune interactions. EMBO J 1999, 18:501-511.
31. Hogg N., Laschinger M., Giles K., McDowall A. T-cell integrins: more than just sticking points. J Cell Sci 2003, 116:4695-4705.
32. Naor D., Sionov R.V., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res 1997, 71:241-319.
33. Marhaba R., Zöller M. CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 2004, 35:211-231.
34. Tsukita S., Oishi K., Sato N., Sagara J., Kawai A., Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994, 126:391-401.
35. Hirao M., Sato N., Kondo T., Yonemura S., Monden M., Sasaki T., et al. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 1996, 135:37-51.